首页> 美国卫生研究院文献>Antimicrobial Resistance and Infection Control >Infections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar Senegal
【2h】

Infections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar Senegal

机译:产生肠杆菌科细菌的广谱β-内酰胺酶引起的感染:塞内加尔达喀尔的两家教学医院住院患者的临床和经济影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundInfections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae (ESBL-E) are of major concern in clinical practice because of limited therapeutic options effective to treat them. Published studies showed that ESBL-E, widely spread in Europe, United States or Asia; are also frequent in Africa. However, the impact of ESBL-E infections is yet to be adequately determined in Sub-Saharan African countries, particularly in Senegal.The aim of our study was to estimate the incidence rate of ESBL-E infections and to assess their clinical and economic impact in Senegal.
机译:背景技术由于生产肠杆菌科细菌的广谱β-内酰胺酶(ESBL-E)引起的感染在临床实践中受到关注,因为有效的治疗选择有限。已发表的研究表明,ESBL-E广泛分布于欧洲,美国或亚洲。在非洲也很常见。然而,在撒哈拉以南非洲国家,特别是在塞内加尔,尚未充分确定ESBL-E感染的影响。我们的研究目的是评估ESBL-E感染的发生率并评估其临床和经济影响在塞内加尔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号